Compugen | CGEN - Actif À Court Terme





Actif À Court Terme Changement Date
Arca Biopharma USD 395.25M 51.39M 2026-03
aTyr Pharma USD 67.58M 178.23M 2026-03
Bio Path USD 677K 14K 2026-03
Brainstorm Cell Therapeutics USD 184K 123K 2026-03
Cara Therapeutics USD 31.54M 6.9M 2025-12
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
Immunic USD 188.76M 165.89M 2026-03
Minerva Neurosciences USD 83.1M 70.08M 2025-12
RedHill Biopharma USD 6.53M 6.03M 2025-12
TherapeuticsMD USD 11.82M 303K 2024-06